1 – 3 of 3
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications.
(
- Contribution to journal › Article
- 2007
-
Mark
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer
(
- Contribution to journal › Article
- 2006
-
Mark
Differential exoprotease activities confer tumor-specific serum peptidome patterns
(
- Contribution to journal › Article